You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 76282-0545


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 76282-0545

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
VILAZODONE HCL 20MG TAB Exelan Pharmaceuticals, Inc. 76282-0545-30 30 80.34 2.67800 2023-03-30 - 2025-09-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for NDC 76282-0545

Understanding the NDC System

Before diving into the market analysis and price projections for the specific NDC 76282-0545, it's essential to understand what an NDC (National Drug Code) is. The NDC is a unique, three-segment number assigned by the FDA to identify drug products. It includes the labeler code, product code, and package code, and is crucial for tracking and managing drug products in the U.S. market[1].

Identifying the Drug

To analyze the market and price projections for NDC 76282-0545, we first need to identify the drug associated with this code. However, the provided sources do not specify the drug corresponding to this NDC. Typically, this information can be found in the FDA's National Drug Code Directory or through other pharmaceutical databases.

Market Analysis

General Pharmaceutical Market Trends

The pharmaceutical market, particularly the biopharma and biotech sectors, is experiencing significant growth driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care. The biopharma market size was estimated to be over $400 billion in 2024, with a projected compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].

Specific Market Segments

For drugs like those identified by NDCs, market analysis often focuses on the therapeutic area, competition, and regulatory environment. For example, in the non-small cell lung cancer (NSCLC) market, immunotherapies and targeted therapies are driving significant growth. Drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025, with sales reaching $17.5 billion collectively in the NSCLC market[4].

Price Projections

General Pricing Trends

Drug prices are influenced by various factors including regulatory changes, competition from generics or biosimilars, and market demand. The median price increase for brand-name drugs was 13.4% in 2022, which can serve as a benchmark for future price adjustments[2].

Specific Price Projections

Without specific data on the drug associated with NDC 76282-0545, it is challenging to provide precise price projections. However, here are some general insights:

  • Brand Name Drugs: Prices for brand-name drugs tend to increase annually, with some drugs experiencing significant price hikes due to market demand and lack of competition.
  • Generic and Biosimilar Impact: The entry of generic or biosimilar versions can significantly reduce the prices of branded drugs. For instance, in the NSCLC market, the sales of generic versions of drugs like Tarceva and Alimta are expected to impact the market negatively for branded versions[4].

Regulatory Environment

The regulatory landscape plays a crucial role in drug pricing and market dynamics. For example, outsourcing facilities that compound drugs may choose to assign NDCs to their products, which can affect their market presence and pricing strategies[1].

Data Management and Reporting

Drug establishments are required to provide the FDA with a current list of all drugs manufactured, prepared, propagated, compounded, or processed for sale in the U.S. This data is published in the NDC Directory, which is updated daily. Accurate and timely reporting is essential for market analysis and price projections[1].

Key Takeaways

  • NDC System: The NDC is a critical identifier for drug products, facilitating tracking and management.
  • Market Trends: The biopharma and biotech markets are growing rapidly, driven by technological advancements and evolving regulatory frameworks.
  • Price Projections: Drug prices are influenced by regulatory changes, competition, and market demand. Specific price projections require detailed data on the drug in question.
  • Regulatory Environment: The FDA's regulations and the choice of assigning NDCs by outsourcing facilities can impact market dynamics.

FAQs

1. What is the National Drug Code (NDC) and its significance? The NDC is a unique three-segment number assigned by the FDA to identify drug products. It is crucial for tracking and managing drug products in the U.S. market.

2. How do regulatory changes impact drug prices? Regulatory changes can significantly impact drug prices by affecting competition, market demand, and the entry of generic or biosimilar versions.

3. What are the key drivers of growth in the biopharma and biotech markets? The key drivers include technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care in clinical trials.

4. How do generic and biosimilar drugs affect the prices of branded drugs? The entry of generic or biosimilar versions can significantly reduce the prices of branded drugs by increasing competition and reducing market demand for the branded versions.

5. Where can I find detailed information about a specific drug using its NDC? Detailed information about a specific drug can be found in the FDA's National Drug Code Directory or through other pharmaceutical databases.

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Latest drug prices and trends for NDC 00378-2245 - DrugPatentWatch
  3. 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
  4. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development
  5. IIS | Code Sets | NDC | Vaccines | CDC - CDC

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.